Effects of low-dose recombinant human brain
natriuretic peptide on anterior myocardial
infarction complicated by cardiogenic shock


Effects of low-dose recombinant human brain
natriuretic peptide on anterior myocardial
infarction complicated by cardiogenic shock
- Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.
ZhiGang Lu ; Jingyu Hang ; Shixin Ma ; Jian Ma ; Meng Wei ;Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery 2017, 32 2
Autor: Yesheng Pan
Fuente: http://www.redalyc.org/articulo.oa?id=398950486007
Introducción
Revista Brasileira de Cirurgia
Cardiovascular-Brazilian Journal of
Cardiovascular Surgery
ISSN: 0102-7638
revista@sbccv.org.br
Sociedade Brasileira de Cirurgia
Cardiovascular
Brasil
Pan, Yesheng; Lu, ZhiGang; Hang, Jingyu; Ma, Shixin; Ma, Jian; Wei, Meng
Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior
Myocardial Infarction Complicated by Cardiogenic Shock
Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery,
vol.
32, núm.
2, 2017, pp.
96-103
Sociedade Brasileira de Cirurgia Cardiovascular
São José do Rio Preto, Brasil
Available in: http:--www.redalyc.org-articulo.oa?id=398950486007
How to cite
Complete issue
More information about this article
Journals homepage in redalyc.org
Scientific Information System
Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal
Non-profit academic project, developed under the open access initiative
Braz J Cardiovasc Surg 2017;32(2):96-103
ORIGINAL ARTICLE
Effects of Low-Dose Recombinant Human Brain
Natriuretic Peptide on Anterior Myocardial
Infarction Complicated by Cardiogenic Shock
Yesheng Pan1, MD; ZhiGang Lu1, MD; Jingyu Hang1, MD; Shixin Ma1, MD; Jian Ma1, MD; Meng Wei1, MD
DOI: 10.21470-1678-9741-2016-0007
Abstract
control (n=23) groups.
In addition to standard therapy, study group
individuals received rhBNP by continuous infusion at 0.005 μg kg−1
min−1 for 72 hours.
Results: Baseline characteristics, medications, and peak of cardiac
troponin I (cTnI) were similar between both groups.
rhBNP treatment
resulted in consistently improved pulmonary capillary wedge
pressure (PCWP) compared to the control group.
Respectively, 7 and
9 patients died in experimental and control groups.
No drug-related
serious adverse events occurred in either group.
Conclusion: When added to standard care in stable patients
with cardiogenic shock complicating anterior STEMI, low dose rhBNP
improves PCWP and is well tolerated.
Keywords: Myocardi...